Brief: Respiratorius: Japan first country to approve VAL001 patent

Respiratorius AB (publ)

04/08/2016 14:13

Aug 4 (Reuters) - Respiratorius publ AB  RESPS.ST : 
    * Japan has as the first country in the world approved Respiratorius patent application 
VAL001, "A Pharmaceutical Composition Comprising a HDAC inhibitor and a Steroid and the Use 
thereof." 
    * The patent gives Respiratorius market exclusivity in Japan for a combination of HDAC 
inhibitors and steroid pre-treatment before chemotherapy (R-CHOP) in the treatment of diffuse 
large B-cell lymphoma (DLBCL)  
 
 Source text: http://bit.ly/2anUjFC 
     
 Further company coverage:  RESPS.ST   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))